United Healthcare Medicare Advantage HMO, United Healthcare Medicare Advantage HMO/POS
What kind of place is this?
AI summary of this centre's website
One Doctor RelationshipResearch FocusedInfusion On-Site
You are stepping into a small, dedicated neurology practice that centers on MS care and infusion treatment. You may appreciate having your neurology visits and infusion services handled in one Knoxville location, along with a patient portal for added convenience.
Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services2/5
Clinical Trials & Research3/5
Insurance & Navigation Help2/5
Scheduling & Virtual Care3/5
About Hope Neurology, PLLC
AI summary of this centre's website
This practice combines MS care, neurology, and onsite infusion services in one Knoxville location. Its patient portal adds convenience to a small-practice setting.
Hope Neurology, PLLC serves people living with multiple sclerosis in Knoxville with a strong focus on neurology and MS care. The practice offers onsite infusion services, including Ocrevus treatment. It operates as a single-location private practice, which may appeal to patients who want a more personal care setting. You can also use a patient portal for payments and communication support.
Good to know
Onsite infusion services are available.
Ocrevus treatment is part of the care options.
A patient portal is available for payments and communication.
The practice hosts a free multiple sclerosis educational event.
Hope Neurology, PLLC is a small, single-location neurology practice in Knoxville that focuses on multiple sclerosis care. You can receive MS care along with infusion services in the same setting, including treatment options such as Ocrevus. It also offers a patient portal and educational content to help you stay informed and involved in your care.
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Closed to new patientsPhase 3
FenebrutinibOcrelizumabPlacebo matched to ocrelizumabPlacebo matched to fenebrutinib
Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.
Information on this page is compiled from public sources including facility websites, ClinicalTrials.gov, CMS data, and AI analysis. It may not be complete or current. Always verify directly with the facility.